Metagenomi, Inc. Common Stock (MGX)

Metagenomi, Inc. Common Stock (MGX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $37.8M; returns 1 day -1.3%, 1 week +2.8%, 1 year -71.0%.

Metagenomi Therapeutics, Inc. (formerly Metagenomi, Inc.) is a precision genetic medicines company focused on developing curative therapeutics for patients by leveraging its proprietary, comprehensive metagenomics-derived gene editing toolbox.

Groups MGX belongs to

• Biotechnology
• Healthcare
• Life Sciences
• Precision Medicine
• Preclinical Development
• Gene Therapy
• R&D
• Rare Diseases
• Pharmaceuticals

MGX financial model: income statement, cash flow and balance sheet